2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$8.93-$0.01 (-0.15%)
Price as of Aug 21, 2026 7:59 PM EDT- $1.5BMarket Cap
- 14.03%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$8.93-$0.01 (-0.15%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.94 | ||
Change | +$0.52 (+6.18%) | ||
Open | $8.44 | ||
High | $9.20 | ||
Low | $8.44 | ||
Previous Close | $8.42 | ||
Volume | 10,448,190 | ||
30-Day Average Volume | 3,873,912 | ||
1-Week Change | 11.06% | ||
1-Month Change | 10.71% | ||
1-Year Change | 14.03% | ||
3-Year Change | 10.78% | ||
5-Year Change | -96.13% | ||
Fundamentals | |||
Shares Outstanding | 164.9M | ||
Total Assets | $955.6M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $18.9M | ||
Net Income | -$53.4M | ||
Free Cash Flow | -$73.4M | ||
EBIT | -$47.1M | ||
EBITDA | -$44.1M | ||
Net Working Capital | $440.5M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 84 | ||
P/B | -8 | ||
P/E | -28 | ||
PEG | 0 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue